Proyeksi Harga SBIO & Analisis ETF - Dividen·Biaya Pengelolaan·Komposisi Saham·NAV·RSI·MACD | Saham AS Hari Ini
10 Nov pukul 4:00 PM ET (Korea 11/11 06:00)Pola grafik yang digambar AI hanya sebagai acuan.
Tabel metrik lengkap
| Category | US Equities - Industry Sector | Expense | 0.5% | Return% 1Y | 30.11% | Total Holdings | 104 | Perf Week | 5.9% | Volume | 28,977 |
| Asset Type | Equities (Stocks) | AUM | $193M | Return% 3Y | 33.58% | NAV | $57.55 | Perf Month | 6.93% | Avg Volume | 0.04M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 4.7% | 52W High | -18.73% | Perf Quarter | -15.04% | Rel Volume | 0.77 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 10.91% | 52W Low | 30.72% | Perf Half Y | 4.43% | Prev Close | $57.60 |
| IPO | 2014/12/31 | Flows% 1M | -3.42% | Return% SI | 8.1% | RSI (14) | 55.67 | Perf YTD | 12.42% | Price | $57.58 |
| Beta | 0.78 | Flows% 3M | 4.96% | Flows% YTD | 41.8% | Flows% 1Y | 83.49% | Perf Year | 29.57% | Volatility(W/M) | 4.07% 3.24% |
| SMA20 | 5.98% | SMA50 | -0.65% | SMA200 | 0.75% | ATR | 1.85 | ||||
ALPS Medical Breakthroughs ETFSBIO | NYSE | Sektor kesehatan ALPS Medical Breakthroughs ETF seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
10 terbesar mencakup 31% dari dana
CRNX Crinetics Pharmaceuticals Inc 4.60% 2 
APGE Apogee Therapeutics Inc 4.29% 3 
CGON Cg Oncology Inc 3.41% 4 
TVTX Travere Therapeutics Inc 3.16% 5 
XENE Xenon Pharmaceuticals Inc 2.99% 6 
DNTH Dianthus Therapeutics Inc 2.96% 7 
ORKA Oruka Therapeutics Inc 2.87% 8 
ACAD Acadia Pharmaceuticals Inc 2.54% 9 
EWTX Edgewise Therapeutics Inc 2.31% 10 
DFTX Definium Therapeutics Inc 2.23% Sektor dengan bobot terbesar lebih dulu.
Dalam 1 tahun terakhir, sedang
19% di bawah harga tertinggi 1 tahun.
Diperdagangkan lebih sedikit dari biasanya. Itu 77% dari volume rata-ratanya.
Menahan lama akan menguntungkan
Jika dibeli 5 tahun lalu, imbal hasil Anda sekarang +24.0%. Dalam periode yang sama S&P 500 mencatat +62%.
Ketuk untuk melihat angka
Harganya bergerak besar
Pada titik terburuk (Februari 2021) turun 63% dan butuh 972 hari untuk pulih.
Ketuk untuk melihat angka
Tidak ada dividen
Belum ada laba untuk dibagikan.
Uang terus masuk
Selama setahun terakhir, uang baru setara 83.5% aset masuk.
Ketuk untuk melihat angka
CURE Direxion Daily Healthcare Bull 3X ETF 211M 
RXL ProShares Ultra Health Care 2X Shares 117M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 40M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 4M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
XBI State Street SPDR S&P Biotech ETF 0.35% 
IYH iShares U.S. Healthcare ETF 0.37% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
